230 related articles for article (PubMed ID: 9210674)
1. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
2. Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus.
Warn PA; Sharp A; Morrissey G; Denning DW
Int J Antimicrob Agents; 2010 Feb; 35(2):146-51. PubMed ID: 20015618
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.
Verweij PE; Oakley KL; Morrissey J; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1998 Apr; 42(4):873-8. PubMed ID: 9559799
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis.
Denning DW; Hall L; Jackson M; Hollis S
Antimicrob Agents Chemother; 1995 Aug; 39(8):1809-14. PubMed ID: 7486923
[TBL] [Abstract][Full Text] [Related]
5. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
Tansho S; Abe S; Ishibashi H; Torii S; Otani H; Ono Y; Yamaguchi H
J Infect Chemother; 2006 Dec; 12(6):355-62. PubMed ID: 17235640
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1997 May; 41(5):1124-6. PubMed ID: 9145880
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
9. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.
Dannaoui E; Borel E; Persat F; Monier MF; Piens MA; Network E
J Med Microbiol; 1999 Dec; 48(12):1087-1093. PubMed ID: 10591162
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
Manavathu EK; Dimmock JR; Vashishtha SC; Cutright J; Chandrasekar PH
J Antimicrob Chemother; 1998 Nov; 42(5):585-90. PubMed ID: 9848441
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole resistance in Aspergillus fumigatus.
Denning DW; Venkateswarlu K; Oakley KL; Anderson MJ; Manning NJ; Stevens DA; Warnock DW; Kelly SL
Antimicrob Agents Chemother; 1997 Jun; 41(6):1364-8. PubMed ID: 9174200
[TBL] [Abstract][Full Text] [Related]
12. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Warn PA; Sharp A; Mosquera J; Spickermann J; Schmitt-Hoffmann A; Heep M; Denning DW
J Antimicrob Chemother; 2006 Dec; 58(6):1198-207. PubMed ID: 17071636
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
[TBL] [Abstract][Full Text] [Related]
16. Acquired itraconazole resistance in Aspergillus fumigatus.
Dannaoui E; Borel E; Monier MF; Piens MA; Picot S; Persat F
J Antimicrob Chemother; 2001 Mar; 47(3):333-40. PubMed ID: 11222566
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
[TBL] [Abstract][Full Text] [Related]
19. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
Denning DW; Radford SA; Oakley KL; Hall L; Johnson EM; Warnock DW
J Antimicrob Chemother; 1997 Sep; 40(3):401-14. PubMed ID: 9338494
[TBL] [Abstract][Full Text] [Related]
20. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
Negri CE; Gonçalves SS; Sousa ACP; Bergamasco MD; Martino MDV; Queiroz-Telles F; Aquino VR; Castro PTO; Hagen F; Meis JF; Colombo AL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
